Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Neo Soma Healthcare vs Sumbare Wellness

Neo Soma Healthcare
Graded #213

Higher grade

vs+3.8999999999999986
Sumbare Wellness
Graded #281

Lower grade

The verdict

Neo Soma Healthcare takes it — 65.8/100 to 61.9/100.

Neo Soma Healthcare grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Neo Soma Healthcare is a multi-product DTC telehealth platform pairing compounded GLP-1 weight management with sexual-health and anti-aging lines.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
66
66
Dose & formulationEven
72
72
Clinical oversightNeo Soma Healthcare +16
72
56
Labs & monitoringNeo Soma Healthcare +10
62
52
FulfillmentSumbare Wellness +2
57
59
Contract termsSumbare Wellness +6
55
61
Neo Soma Healthcare · left barSumbare Wellness · right bar

The numbers

MetricNeo Soma HealthcareSumbare Wellness
WeighScore65.8/10061.9/100
GradeCC
Scorecard rank#213#281
Semaglutide$199/mo$199/mo (all doses, compounded)
Tirzepatide$330/mo$199/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Neo Soma Healthcare

Graded #213 · C

Strengths

  • LegitScript verification badge present
  • Publishes the FDA compounded-medication disclaimer
  • Pricing shown publicly for all 6 product lines
  • Multi-product platform (GLP-1, sexual health, peptide therapies)
  • First-month discount on semaglutide ($99 entry)

Where it loses points

  • Pharmacy partner not named (503A vs 503B unclear)
  • States served not listed — no per-state availability table
  • No named medical director
  • Standard semaglutide pricing ($199/mo) above the cheapest providers ($150–180/mo)
  • Tirzepatide entry pricing ($330) above the cheapest providers (~$200–250/mo)
Sumbare Wellness

Graded #281 · C

Strengths

  • One flat $199/month price covering medication, provider review and shipping, with no consultation fee and no dose-change surcharge
  • Charges nothing if a provider does not approve you
  • Offers a deliberate low-dose microdosing protocol aimed at body composition, which most competitors do not break out
  • Publishes a named legal entity, a US mailing address and a working phone number
  • Pre-screening quiz is short and asks your goal before any medical question

Where it loses points

  • Cancellation terms contradict three ways: the homepage says cancel anytime, the Terms say 48 hours notice, the FAQ says 30 days
  • Availability is unclear: the homepage counter reads 3 states while the treatment pages say telehealth nationwide, and no state list is published
  • Its chart cites placebo-controlled trials of compounded semaglutide and tirzepatide, which do not exist; those trials studied the branded drugs
  • No compounding pharmacy is named, and neither 503A nor 503B appears anywhere on the site
  • Any returned prescription is charged a $35 disposal fee, and prescription orders cannot be cancelled at all after 24 hours

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard